tiprankstipranks
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe FlyMural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
7d ago
Premium
Ratings
Promising Developments in Mural Oncology Plc’s ARTISTRY-7 Trial Boost Buy Rating
18d ago
Premium
Ratings
Promising Outlook for Mural Oncology: Buy Rating Driven by Nemvaleukin’s Potential and Strategic Trials
20d ago
PremiumCompany AnnouncementsMural Oncology Advances Drug Pipeline and Extends Runway
3M ago
Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
4M ago
Mural Oncology files $300M mixed securities shelf
Premium
The Fly
Mural Oncology files $300M mixed securities shelf
5M ago
Mural Oncology ‘undervalued,’ initiated with Strong Buy at Raymond James
PremiumThe FlyMural Oncology ‘undervalued,’ initiated with Strong Buy at Raymond James
6M ago
Premium
Company Announcements
Mural Oncology’s Investor Day Highlights Cancer Treatment Trials
6M ago
Mural Oncology provides update on ARTISTRY-7 at Investor Day
Premium
The Fly
Mural Oncology provides update on ARTISTRY-7 at Investor Day
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100